25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Mural Oncology plc
Buy, Hold or Sell?

Let's analyze Mural Oncology plc together

I guess you are interested in Mural Oncology plc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Mural Oncology plc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Mural Oncology plc

I send you an email if I find something interesting about Mural Oncology plc.

1. Quick Overview

1.1. Quick analysis of Mural Oncology plc (30 sec.)










1.2. What can you expect buying and holding a share of Mural Oncology plc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$10.21
Expected worth in 1 year
$20.82
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
$10.61
Return On Investment
265.9%

For what price can you sell your share?

Current Price per Share
$3.99
Expected price per share
$3.26 - $5.1199
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Mural Oncology plc (5 min.)




Live pricePrice per Share (EOD)
$3.99

2.2. Growth of Mural Oncology plc (5 min.)




Is Mural Oncology plc growing?

Current yearPrevious yearGrowGrow %
How rich?$174.1m$58.5m$160.7m73.3%

How much money is Mural Oncology plc making?

Current yearPrevious yearGrowGrow %
Making money-$38.4m-$52.2m$13.7m35.8%
Net Profit Margin-568.5%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Mural Oncology plc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Mural Oncology plc?

Welcome investor! Mural Oncology plc's management wants to use your money to grow the business. In return you get a share of Mural Oncology plc.

First you should know what it really means to hold a share of Mural Oncology plc. And how you can make/lose money.

Speculation

The Price per Share of Mural Oncology plc is $3.99. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Mural Oncology plc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Mural Oncology plc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $10.21. Based on the TTM, the Book Value Change Per Share is $2.65 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Mural Oncology plc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.86-46.7%-2.25-56.5%-3.06-76.7%-2.66-66.6%-2.66-66.6%
Usd Book Value Change Per Share-1.78-44.7%2.6566.5%-0.10-2.5%1.2832.0%1.2832.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.78-44.7%2.6566.5%-0.10-2.5%1.2832.0%1.2832.0%
Usd Price Per Share3.13-4.27-0.00-2.14-2.14-
Price to Earnings Ratio-0.42--0.49-0.00--0.24--0.24-
Price-to-Total Gains Ratio-1.75--1.51--1.51--1.51-
Price to Book Ratio0.31-0.33-0.00-0.16-0.16-
Price-to-Total Gains Ratio-1.75--1.51--1.51--1.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.99
Number of shares250
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share2.651.28
Usd Total Gains Per Share2.651.28
Gains per Quarter (250 shares)663.21318.98
Gains per Year (250 shares)2,652.841,275.92
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1026532643012761266
2053065296025522542
3079597949038283818
401061110602051045094
501326413255063806370
601591715908076567646
701857018561089318922
80212232121401020710198
90238762386701148311474
100265282652001275912750

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.08.00.00.0%0.08.00.00.0%0.08.00.00.0%0.08.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.05.01.025.0%2.05.01.025.0%2.05.01.025.0%2.05.01.025.0%
Dividend per Share0.00.04.00.0%0.00.08.00.0%0.00.08.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share1.03.00.025.0%2.05.01.025.0%2.05.01.025.0%2.05.01.025.0%2.05.01.025.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Mural Oncology plc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.7842.653-167%-0.101-94%1.276-240%1.276-240%
Book Value Per Share--10.20712.858-21%3.434+197%8.146+25%8.146+25%
Current Ratio--7.3779.214-20%11.907-38%10.561-30%10.561-30%
Debt To Asset Ratio--0.1430.127+13%1.142-87%0.634-77%0.634-77%
Debt To Equity Ratio--0.1670.145+15%0.014+1057%0.080+109%0.080+109%
Dividend Per Share----0%-0%-0%-0%
Eps---1.862-2.253+21%-3.061+64%-2.657+43%-2.657+43%
Free Cash Flow Per Share---1.764-2.062+17%-2.811+59%-2.437+38%-2.437+38%
Free Cash Flow To Equity Per Share---1.7522.557-169%--100%1.278-237%1.278-237%
Gross Profit Margin--1.0001.009-1%1.0010%1.0050%1.0050%
Market Cap68070597.000+22%53398739.00072847481.000-27%-+100%36423740.500+47%36423740.500+47%
Net Profit Margin----5.6850%-0%-2.8430%-2.8430%
Operating Margin----5.4970%-0%-2.7480%-2.7480%
Operating Ratio---5.646-100%-0%2.823-100%2.823-100%
Pb Ratio0.391+22%0.3070.327-6%-+100%0.163+88%0.163+88%
Pe Ratio-0.536-27%-0.420-0.486+16%--100%-0.243-42%-0.243-42%
Price Per Share3.990+22%3.1304.270-27%-+100%2.135+47%2.135+47%
Price To Free Cash Flow Ratio-0.566-27%-0.444-0.508+15%--100%-0.254-43%-0.254-43%
Price To Total Gains Ratio-2.237-27%-1.755-1.509-14%---1.509-14%-1.509-14%
Quick Ratio--9.68811.948-19%11.495-16%11.721-17%11.721-17%
Return On Assets---0.156-0.151-3%-1.248+699%-0.700+348%-0.700+348%
Return On Equity---0.182-0.173-5%-0.046-75%-0.110-40%-0.110-40%
Total Gains Per Share---1.7842.653-167%-0.101-94%1.276-240%1.276-240%
Usd Book Value--174141000.000219364500.000-21%58580000.000+197%138972250.000+25%138972250.000+25%
Usd Book Value Change Per Share---1.7842.653-167%-0.101-94%1.276-240%1.276-240%
Usd Book Value Per Share--10.20712.858-21%3.434+197%8.146+25%8.146+25%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.862-2.253+21%-3.061+64%-2.657+43%-2.657+43%
Usd Free Cash Flow---30092000.000-35186750.000+17%-47956750.000+59%-41571750.000+38%-41571750.000+38%
Usd Free Cash Flow Per Share---1.764-2.062+17%-2.811+59%-2.437+38%-2.437+38%
Usd Free Cash Flow To Equity Per Share---1.7522.557-169%--100%1.278-237%1.278-237%
Usd Market Cap68070597.000+22%53398739.00072847481.000-27%-+100%36423740.500+47%36423740.500+47%
Usd Price Per Share3.990+22%3.1304.270-27%-+100%2.135+47%2.135+47%
Usd Profit---31759000.000-38444000.000+21%-52215000.000+64%-45329500.000+43%-45329500.000+43%
Usd Revenue---654500.000-100%-0%327250.000-100%327250.000-100%
Usd Total Gains Per Share---1.7842.653-167%-0.101-94%1.276-240%1.276-240%
 EOD+5 -3MRQTTM+9 -23YOY+16 -135Y+17 -1510Y+17 -15

3.3 Fundamental Score

Let's check the fundamental score of Mural Oncology plc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.536
Price to Book Ratio (EOD)Between0-10.391
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than19.688
Current Ratio (MRQ)Greater than17.377
Debt to Asset Ratio (MRQ)Less than10.143
Debt to Equity Ratio (MRQ)Less than10.167
Return on Equity (MRQ)Greater than0.15-0.182
Return on Assets (MRQ)Greater than0.05-0.156
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Mural Oncology plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.145
Ma 20Greater thanMa 503.536
Ma 50Greater thanMa 1003.458
Ma 100Greater thanMa 2003.379
OpenGreater thanClose4.070
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Mural Oncology plc

Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company is also developing engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.

Fundamental data was last updated by Penke on 2024-11-23 00:30:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Mural Oncology plc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Mural Oncology plc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Mural Oncology plc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-568.5%+568.5%
TTM-568.5%YOY--568.5%
TTM-568.5%5Y-284.3%-284.3%
5Y-284.3%10Y-284.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--113.9%+113.9%
TTM-568.5%-214.4%-354.1%
YOY--210.0%+210.0%
5Y-284.3%-339.1%+54.8%
10Y-284.3%-464.5%+180.2%
4.3.1.2. Return on Assets

Shows how efficient Mural Oncology plc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Mural Oncology plc to the Biotechnology industry mean.
  • -15.6% Return on Assets means that Mural Oncology plc generated $-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Mural Oncology plc:

  • The MRQ is -15.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.6%TTM-15.1%-0.5%
TTM-15.1%YOY-124.8%+109.6%
TTM-15.1%5Y-70.0%+54.8%
5Y-70.0%10Y-70.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.6%-11.1%-4.5%
TTM-15.1%-11.7%-3.4%
YOY-124.8%-11.3%-113.5%
5Y-70.0%-12.7%-57.3%
10Y-70.0%-14.3%-55.7%
4.3.1.3. Return on Equity

Shows how efficient Mural Oncology plc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Mural Oncology plc to the Biotechnology industry mean.
  • -18.2% Return on Equity means Mural Oncology plc generated $-0.18 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Mural Oncology plc:

  • The MRQ is -18.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -17.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.2%TTM-17.3%-0.9%
TTM-17.3%YOY-4.6%-12.8%
TTM-17.3%5Y-11.0%-6.4%
5Y-11.0%10Y-11.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.2%-14.2%-4.0%
TTM-17.3%-15.8%-1.5%
YOY-4.6%-14.2%+9.6%
5Y-11.0%-18.5%+7.5%
10Y-11.0%-19.5%+8.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Mural Oncology plc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Mural Oncology plc is operating .

  • Measures how much profit Mural Oncology plc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Mural Oncology plc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Mural Oncology plc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-549.7%+549.7%
TTM-549.7%YOY--549.7%
TTM-549.7%5Y-274.8%-274.8%
5Y-274.8%10Y-274.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--224.9%+224.9%
TTM-549.7%-306.4%-243.3%
YOY--223.5%+223.5%
5Y-274.8%-386.5%+111.7%
10Y-274.8%-497.6%+222.8%
4.3.2.2. Operating Ratio

Measures how efficient Mural Oncology plc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Mural Oncology plc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM5.646-5.646
TTM5.646YOY-+5.646
TTM5.6465Y2.823+2.823
5Y2.82310Y2.8230.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.508-2.508
TTM5.6463.295+2.351
YOY-3.298-3.298
5Y2.8234.788-1.965
10Y2.8236.517-3.694
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Mural Oncology plc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Mural Oncology plc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.38 means the company has $7.38 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Mural Oncology plc:

  • The MRQ is 7.377. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.214. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.377TTM9.214-1.837
TTM9.214YOY11.907-2.693
TTM9.2145Y10.561-1.347
5Y10.56110Y10.5610.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.3773.645+3.732
TTM9.2143.877+5.337
YOY11.9074.666+7.241
5Y10.5615.938+4.623
10Y10.5616.265+4.296
4.4.3.2. Quick Ratio

Measures if Mural Oncology plc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Mural Oncology plc to the Biotechnology industry mean.
  • A Quick Ratio of 9.69 means the company can pay off $9.69 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Mural Oncology plc:

  • The MRQ is 9.688. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 11.948. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ9.688TTM11.948-2.259
TTM11.948YOY11.495+0.453
TTM11.9485Y11.721+0.226
5Y11.72110Y11.7210.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.6883.093+6.595
TTM11.9483.432+8.516
YOY11.4954.478+7.017
5Y11.7215.927+5.794
10Y11.7216.424+5.297
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Mural Oncology plc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Mural Oncology plc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Mural Oncology plc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.14 means that Mural Oncology plc assets are financed with 14.3% credit (debt) and the remaining percentage (100% - 14.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Mural Oncology plc:

  • The MRQ is 0.143. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.127. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.143TTM0.127+0.017
TTM0.127YOY1.142-1.015
TTM0.1275Y0.634-0.507
5Y0.63410Y0.6340.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1430.354-0.211
TTM0.1270.345-0.218
YOY1.1420.311+0.831
5Y0.6340.366+0.268
10Y0.6340.383+0.251
4.5.4.2. Debt to Equity Ratio

Measures if Mural Oncology plc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Mural Oncology plc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 16.7% means that company has $0.17 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Mural Oncology plc:

  • The MRQ is 0.167. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.145. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.167TTM0.145+0.022
TTM0.145YOY0.014+0.131
TTM0.1455Y0.080+0.065
5Y0.08010Y0.0800.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1670.396-0.229
TTM0.1450.436-0.291
YOY0.0140.380-0.366
5Y0.0800.451-0.371
10Y0.0800.493-0.413
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Mural Oncology plc generates.

  • Above 15 is considered overpriced but always compare Mural Oncology plc to the Biotechnology industry mean.
  • A PE ratio of -0.42 means the investor is paying $-0.42 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Mural Oncology plc:

  • The EOD is -0.536. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.420. Based on the earnings, the company is expensive. -2
  • The TTM is -0.486. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.536MRQ-0.420-0.115
MRQ-0.420TTM-0.486+0.065
TTM-0.486YOY--0.486
TTM-0.4865Y-0.243-0.243
5Y-0.24310Y-0.2430.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.536-2.220+1.684
MRQ-0.420-2.398+1.978
TTM-0.486-3.148+2.662
YOY--3.237+3.237
5Y-0.243-6.033+5.790
10Y-0.243-6.685+6.442
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Mural Oncology plc:

  • The EOD is -0.566. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.444. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.508. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.566MRQ-0.444-0.122
MRQ-0.444TTM-0.508+0.065
TTM-0.508YOY--0.508
TTM-0.5085Y-0.254-0.254
5Y-0.25410Y-0.2540.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.566-2.988+2.422
MRQ-0.444-3.276+2.832
TTM-0.508-3.734+3.226
YOY--4.523+4.523
5Y-0.254-8.321+8.067
10Y-0.254-9.273+9.019
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Mural Oncology plc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.31 means the investor is paying $0.31 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Mural Oncology plc:

  • The EOD is 0.391. Based on the equity, the company is cheap. +2
  • The MRQ is 0.307. Based on the equity, the company is cheap. +2
  • The TTM is 0.327. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.391MRQ0.307+0.084
MRQ0.307TTM0.327-0.020
TTM0.327YOY-+0.327
TTM0.3275Y0.163+0.163
5Y0.16310Y0.1630.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.3911.894-1.503
MRQ0.3072.027-1.720
TTM0.3272.356-2.029
YOY-2.418-2.418
5Y0.1633.686-3.523
10Y0.1634.357-4.194
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Mural Oncology plc.

4.8.3. Insider Transactions

Insiders are holding 1.147% of the shares of Mural Oncology plc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-10-31Adam D CutlerSELL74213.41
2024-07-18Maiken Keson-brookesSELL21573.41
2024-07-08Caroline LoewSELL125312.91
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets203,274
Total Liabilities29,133
Total Stockholder Equity174,141
 As reported
Total Liabilities 29,133
Total Stockholder Equity+ 174,141
Total Assets = 203,274

Assets

Total Assets203,274
Total Current Assets183,794
Long-term Assets19,480
Total Current Assets
Cash And Cash Equivalents 111,018
Short-term Investments 64,483
Net Receivables 1,393
Other Current Assets 6,900
Total Current Assets  (as reported)183,794
Total Current Assets  (calculated)183,794
+/-0
Long-term Assets
Property Plant Equipment 17,484
Long-term Assets Other 1,996
Long-term Assets  (as reported)19,480
Long-term Assets  (calculated)19,480
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities24,914
Long-term Liabilities4,219
Total Stockholder Equity174,141
Total Current Liabilities
Short-term Debt 5,442
Accounts payable 2,241
Other Current Liabilities 22,673
Total Current Liabilities  (as reported)24,914
Total Current Liabilities  (calculated)30,356
+/- 5,442
Long-term Liabilities
Long-term Liabilities  (as reported)4,219
Long-term Liabilities  (calculated)0
+/- 4,219
Total Stockholder Equity
Common Stock170
Retained Earnings -125,097
Other Stockholders Equity 299,068
Total Stockholder Equity (as reported)174,141
Total Stockholder Equity (calculated)174,141
+/-0
Other
Cash and Short Term Investments 175,501
Common Stock Shares Outstanding 17,029
Liabilities and Stockholders Equity 203,274
Net Debt -101,472
Net Working Capital 158,880
Short Long Term Debt Total 9,546



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-30
> Total Assets 
0
33,750
0
300,983
30,202
301,745
263,504
234,928
203,274
203,274234,928263,504301,74530,202300,983033,7500
   > Total Current Assets 
0
4,817
0
274,820
4,961
277,337
239,428
213,059
183,794
183,794213,059239,428277,3374,961274,82004,8170
       Cash And Cash Equivalents 
0
-19,386
0
273,339
-16,480
270,852
107,263
121,587
111,018
111,018121,587107,263270,852-16,480273,3390-19,3860
       Short-term Investments 
0
0
0
0
0
0
124,411
83,117
64,483
64,48383,117124,411000000
       Net Receivables 
0
0
0
0
0
5,548
1,895
1,005
1,393
1,3931,0051,8955,54800000
       Other Current Assets 
0
1,830
0
0
2,703
937
5,859
7,350
6,900
6,9007,3505,8599372,703001,8300
   > Long-term Assets 
0
28,933
0
26,163
25,241
24,408
24,076
21,869
19,480
19,48021,86924,07624,40825,24126,163028,9330
       Property Plant Equipment 
0
28,933
0
24,502
25,060
24,150
22,030
19,839
17,484
17,48419,83922,03024,15025,06024,502028,9330
> Total Liabilities 
0
55,406
0
16,459
37,094
37,928
28,577
30,355
29,133
29,13330,35528,57737,92837,09416,459055,4060
   > Total Current Liabilities 
0
41,560
0
5,807
26,408
29,017
21,247
24,625
24,914
24,91424,62521,24729,01726,4085,807041,5600
       Short-term Debt 
0
5,844
0
5,807
6,013
12,196
6,156
10,700
5,442
5,44210,7006,15612,1966,0135,80705,8440
       Accounts payable 
0
2,966
0
0
3,501
5,973
1,567
3,108
2,241
2,2413,1081,5675,9733,501002,9660
       Other Current Liabilities 
0
32,750
0
0
13,393
10,848
13,524
10,817
22,673
22,67310,81713,52410,84813,3930032,7500
   > Long-term Liabilities 
0
13,846
0
10,652
10,686
8,911
7,330
5,730
4,219
4,2195,7307,3308,91110,68610,652013,8460
> Total Stockholder Equity
0
-21,656
0
284,524
-6,892
263,817
234,927
204,573
174,141
174,141204,573234,927263,817-6,892284,5240-21,6560
   Common Stock
0
0
0
167
0
167
169
169
170
1701691691670167000
   Retained Earnings Total Equity000000000
   Accumulated Other Comprehensive Income 0-54-740-6,89200-21,6560
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
0
0
0
284,357
0
294,507
296,532
297,742
299,068
299,068297,742296,532294,5070284,357000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-2,567
Gross Profit-2,567-2,567
 
Operating Income (+$)
Gross Profit-2,567
Operating Expense-192,071
Operating Income-194,638-194,638
 
Operating Expense (+$)
Research Development162,032
Selling General Administrative30,706
Selling And Marketing Expenses667
Operating Expense192,071193,405
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-194,638
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-195,287-193,989
EBIT - interestExpense = -195,287
-195,287
-207,447
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-195,287-195,287
Earnings Before Interest and Taxes (EBITDA)-192,720
 
After tax Income (+$)
Income Before Tax-195,287
Tax Provision-12,160
Net Income From Continuing Ops-207,447-207,447
Net Income-207,447
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses194,638
Total Other Income/Expenses Net-6490
 

Technical Analysis of Mural Oncology plc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Mural Oncology plc. The general trend of Mural Oncology plc is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Mural Oncology plc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Mural Oncology plc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 4.1831 < 4.27 < 5.1199.

The bearish price targets are: 3.92 > 3.69 > 3.26.

Tweet this
Mural Oncology plc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Mural Oncology plc. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Mural Oncology plc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Mural Oncology plc. The current macd is 0.10943594.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Mural Oncology plc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Mural Oncology plc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Mural Oncology plc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Mural Oncology plc Daily Moving Average Convergence/Divergence (MACD) ChartMural Oncology plc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Mural Oncology plc. The current adx is 22.66.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Mural Oncology plc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Mural Oncology plc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Mural Oncology plc. The current sar is 3.30939608.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Mural Oncology plc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Mural Oncology plc. The current rsi is 70.14. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending down: The RSI is trending down. -1
Mural Oncology plc Daily Relative Strength Index (RSI) ChartMural Oncology plc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Mural Oncology plc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Mural Oncology plc price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Mural Oncology plc Daily Stochastic Oscillator ChartMural Oncology plc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Mural Oncology plc. The current cci is 177.08.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Mural Oncology plc Daily Commodity Channel Index (CCI) ChartMural Oncology plc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Mural Oncology plc. The current cmo is 51.16.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Mural Oncology plc Daily Chande Momentum Oscillator (CMO) ChartMural Oncology plc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Mural Oncology plc. The current willr is -27.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Mural Oncology plc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Mural Oncology plc Daily Williams %R ChartMural Oncology plc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Mural Oncology plc.

Mural Oncology plc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Mural Oncology plc. The current atr is 0.21906638.

Mural Oncology plc Daily Average True Range (ATR) ChartMural Oncology plc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Mural Oncology plc. The current obv is 10,987,665.

Mural Oncology plc Daily On-Balance Volume (OBV) ChartMural Oncology plc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Mural Oncology plc. The current mfi is 85.97.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Mural Oncology plc Daily Money Flow Index (MFI) ChartMural Oncology plc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Mural Oncology plc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

Mural Oncology plc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Mural Oncology plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.145
Ma 20Greater thanMa 503.536
Ma 50Greater thanMa 1003.458
Ma 100Greater thanMa 2003.379
OpenGreater thanClose4.070
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Mural Oncology plc with someone you think should read this too:
  • Are you bullish or bearish on Mural Oncology plc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Mural Oncology plc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Mural Oncology plc

I send you an email if I find something interesting about Mural Oncology plc.


Comments

How you think about this?

Leave a comment

Stay informed about Mural Oncology plc.

Receive notifications about Mural Oncology plc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.